Cargando…
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy
Monoclonal antibodies (MAbs) targeting the Spike glycoprotein of SARS-CoV-2 is a key strategy to prevent severe COVID-19. Here, the efficacy of two monoclonal antibody bitherapies against SARS-CoV-2 was assessed on 92 patients at high risk of severe COVID-19 between March and October 2021 (Bichat-Cl...
Autores principales: | Ferré, Valentine Marie, Peiffer-Smadja, Nathan, Kramer, Laura, Coppée, Romain, Kante, Aïcha, Debarge, Margaux, Choquet, Christophe, Saint Joannis, Thibault, Bouzid, Donia, Messika, Jonathan, Le Grand, Jennifer, Thy, Michael, Kernéis, Solen, Descamps, Diane, Visseaux, Benoit, Ghosn, Jade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603708/ https://www.ncbi.nlm.nih.gov/pubmed/36125289 http://dx.doi.org/10.1128/spectrum.02152-22 |
Ejemplares similares
-
Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022) -
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021) -
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial
por: Bouzid, Donia, et al.
Publicado: (2021) -
Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study
por: Bouzid, Donia, et al.
Publicado: (2023) -
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
por: Visseaux, Benoit, et al.
Publicado: (2020)